Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.96% vs 6.47% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -24.84% vs -6.70% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -11.89% vs 20.64% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -19.57% vs 29.94% in Mar 2025
Compare Profit and Loss Results of TTK Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
857.00
2,494.00
-1,637.00
-65.64%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
857.00
2,494.00
-1,637.00
-65.64%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
403.00
1,046.00
-643.00
-61.47%
Power & Fuel Cost
24.00
41.00
-17.00
-41.46%
Employee Cost
165.00
255.00
-90.00
-35.29%
Operating Expenses
31.00
660.00
-629.00
-95.30%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
145.00
68.00
77.00
113.24%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
85.00
-76.00
-89.41%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
831.00
2,197.00
-1,366.00
-62.18%
Operating Profit (PBDIT) excl Other Income
26.00
296.00
-270.00
-91.22%
Other Income
72.00
83.00
-11.00
-13.25%
Operating Profit (PBDIT)
98.00
379.00
-281.00
-74.14%
Interest
2.00
16.00
-14.00
-87.50%
Profit before Depriciation and Tax
95.00
363.00
-268.00
-73.83%
Depreciation
8.00
49.00
-41.00
-83.67%
Profit Before Taxation & Exceptional Items
86.00
313.00
-227.00
-72.52%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
82.00
313.00
-231.00
-73.80%
Provision for Tax
16.00
80.00
-64.00
-80.00%
Profit After Tax
65.00
232.00
-167.00
-71.98%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
940.00
949.00
-9.00
-0.95%
Profit Available for appropriations
1,005.00
1,182.00
-177.00
-14.97%
Appropriations
1,005.00
1,182.00
-177.00
-14.97%
Equity Dividend (%)
100%
85%
15.00
Earnings Per Share
46.48
13.61
32.87
241.51%
Profit And Loss - Net Sales
Net Sales 857.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.96% vs 6.47% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -24.84% vs -6.70% in Mar 2025
Profit And Loss - Interest
Interest 2.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.89% vs 20.64% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 65.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -19.57% vs 29.94% in Mar 2025






